INT232508

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.43
First Reported 2008
Last Reported 2010
Negated 3
Speculated 2
Reported most in Body
Documents 4
Total Number 5
Disease Relevance 2.73
Pain Relevance 0.13

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cytoplasm (CD34) cell proliferation (CD34) signal transduction (CD34)
extracellular region (CD34) cell adhesion (CD34) cell motility (CD34)
CD34 (Homo sapiens)
Pain Link Frequency Relevance Heat
Inflammation 28 63.20 Quite High
Arthritis 56 62.16 Quite High
rheumatoid arthritis 32 21.12 Low Low
agonist 6 5.00 Very Low Very Low Very Low
Nicotine 4 5.00 Very Low Very Low Very Low
ischemia 4 5.00 Very Low Very Low Very Low
Pain 4 5.00 Very Low Very Low Very Low
cytokine 3 5.00 Very Low Very Low Very Low
anesthesia 2 5.00 Very Low Very Low Very Low
Bioavailability 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Muscular Dystrophy 70 98.52 Very High Very High Very High
Thrombosis 6 96.56 Very High Very High Very High
Myocardial Infarction 23 94.32 High High
Death 14 94.00 High High
Left Ventricular Dysfunction 2 88.88 High High
Hypersensitivity 6 87.68 High High
Acute Coronary Syndrome 7 87.36 High High
Diabetes Mellitus 11 86.80 High High
Obesity 11 84.72 Quite High
Disease 23 83.76 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Expression of CD34 in CD34-enriched CB-MNCs was not affected (Figure 4a).
Neg (not) Regulation (affected) of Gene_expression (Expression) of CD34
1) Confidence 0.43 Published 2010 Journal Arthritis Res Ther Section Body Doc Link PMC2875643 Disease Relevance 0.31 Pain Relevance 0.06
The study showed that the CD34-covered stents were safe and effective, with satisfactory immediate results and mid-term outcome, without evidence of stent thrombosis
Regulation (effective) of Gene_expression (stents) of CD34-covered associated with thrombosis
2) Confidence 0.42 Published 2010 Journal J Angiogenes Res Section Body Doc Link PMC2834645 Disease Relevance 0.98 Pain Relevance 0
Moreover, we observed that the nature of the dystrophin gene mutation did not affect the levels of both CD133+CXCR4+CD34- and CD133+CXCR4+CD34+ cells in the DMD subjects analyzed in this study.
Neg (not) Regulation (affect) of Spec (analyzed) Gene_expression (levels) of CD34 associated with muscular dystrophy
3) Confidence 0.40 Published 2008 Journal PLoS ONE Section Body Doc Link PMC2377332 Disease Relevance 0.78 Pain Relevance 0
MSC have been defined as the cells having plastic-adherence when maintained under standard culture conditions, must have the ability of osteogenic, adipogenic and chondrogenic differentiation, must express CD73, CD90, and CD105, and must lack expression of hematopoietic lineage markers c-kit, CD14, CD34, CD 45, CD 11b, CD 29, CD79?
Spec (must) Regulation (lack) of Gene_expression (expression) of CD34
4) Confidence 0.33 Published 2010 Journal Stem Cells International Section Body Doc Link PMC3010655 Disease Relevance 0.36 Pain Relevance 0
Expression of CD34 in CD34-enriched CB-MNCs was not affected (Figure 4a).
Neg (not) Regulation (affected) of Gene_expression (Expression) of CD34
5) Confidence 0.31 Published 2010 Journal Arthritis Res Ther Section Body Doc Link PMC2875643 Disease Relevance 0.31 Pain Relevance 0.06

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox